|
|
780 Plantation Drive
Burlington, NC 27215 USA
phone:(336) 222-9707
fax:(336) 222-8819
|
|
| Symbol |
BDX |
| Exchange |
|
| Founded |
1996 |
| Employees |
340 |
|
|
| www.tripathimaging.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| TriPath Imaging was acquired by BD, a leading global medical technology company, on December 20, 2006 |
|
| Management |
|
| |
|
|
|
|
|
|
|
| Keywords |
| diagnostics, cytopathology, histopathology, cervical cancer screening, molecular diagnostic, cancer, cervix, breast, ovary, Urology, prostate, urinary, bladder, erectile |
|
|
|
| Description |
|
TriPath Imaging was acquired by BD, a leading global medical technology company, on December 20, 2006.
TriPath Imaging, Inc. develops, manufactures, markets, and sells solutions to improve the clinical management of cancer, including detection, diagnosis, staging, and treatment. TriPath Oncology, Inc., a wholly-owned subsidiary of TriPath Imaging, develops and manages the market introduction of molecular diagnostic and pharmacogenomic products and services for cancers of the cervix, breast, ovary, and prostate. |
|
| Products / Services |
Through the Company's Commercial Operations group, they have developed and are marketing an effective solution for cervical cancer screening in conjunction with other products that deliver image management, data handling, and prognostic tools for cell diagnosis, cytopathology, and histopathology.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members